Similar studies have found that NAC (500 mg/kg, i.p.), like Tetramethylpyrazine (TMP) (100 mg/kg, p.o.), reduces KIM-1 levels in rat models of AKI [43]. This evidence concerns the gene HAVCR1 and acute kidney injury.